Chung Chun

Chung Chun is the Chief Technology Officer and Co-Founder of Bionova Scientific.

Prior to co-founding Bionova in 2014, Chung spent nearly 20 years in the biopharmaceutical industry, establishing an impressive track record of delivering technical results and achieving business goals. Much of her pre-Bionova career was at Abgenix, Amgen and Boehringer Ingelheim.

Most recently, Chung was a Senior Manager at Boehringer Ingelheim overseeing process development, tech transfer, and GMP campaigns for BI’s CDMO operations.

During her prior tenure at Abgenix (and later as part of Amgen), she was instrumental in the development and production of Vectibix®. For 10 years, she shepherded the product from the R&D stage, through IND and BLA filings, and into commercial GMP production.

Chung’s technical experience and expertise focus on clinical and commercial upstream process development, process characterization; cGMP facility design and buildout including stainless steel and single-use technologies; manufacturing operations including Tox, Phase I, II, III and commercial; clinical and regulatory affairs including IND & BLA filings; and commercial product audits including FDA, EMEA, KFDA, ANVISA, PMDA & CFIA.

Chung earned her B.A. in Molecular and Cell Biology at the University of California, Berkeley.